Nykredit A S Invests $13.71 Million in Humana Inc. $HUM

Nykredit A S acquired a new position in shares of Humana Inc. (NYSE:HUM) in the second quarter, HoldingsChannel reports. The institutional investor acquired 34,503 shares of the insurance provider’s stock, valued at approximately $13,705,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. BlackRock Inc. bought a new position in shares of Humana during the second quarter worth approximately $4,138,160,000. Pzena Investment Management LLC bought a new stake in shares of Humana during the 2nd quarter worth $1,749,014,000. Capital International Investors boosted its stake in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares in the last quarter. Norges Bank bought a new position in Humana in the fourth quarter valued at about $456,632,000. Finally, Wellington Management Group LLP grew its position in Humana by 4,481.7% in the fourth quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after acquiring an additional 1,170,387 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on HUM shares. Mizuho increased their target price on shares of Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a research report on Thursday, July 30th. They set a “hold” rating for the company. JPMorgan Chase & Co. increased their price objective on shares of Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a research note on Monday, August 10th. Guggenheim boosted their target price on shares of Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Finally, TD Cowen upped their price target on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $403.91.

Humana Stock Down 1.4%

NYSE:HUM opened at $400.70 on Friday. The firm’s 50 day simple moving average is $388.44 and its 200 day simple moving average is $296.00. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company has a market cap of $48.12 billion, a PE ratio of 37.91, a P/E/G ratio of 2.67 and a beta of 0.74.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue was up 26.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.27 EPS. On average, research analysts anticipate that Humana Inc. will post 9 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s dividend payout ratio is presently 33.49%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.